🇺🇸 FDA
Patent

US 11191821

Peptide vaccine formulations and use thereof for inducing an immune response

granted A61KA61K2039/555A61K2039/55555

Quick answer

US patent 11191821 (Peptide vaccine formulations and use thereof for inducing an immune response) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/555, A61K2039/55555, A61K2039/60, A61K2039/6093